Cargando…

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

BACKGROUND: Impairment in daily functioning is a clinical hallmark of dementia. Difficulties with “instrumental activities of daily living” (IADL) seem to increase gradually over the course of Alzheimer’s disease (AD), before dementia onset. However, it is currently not well established how difficul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubbelman, Mark A., Jutten, Roos J., Tomaszewski Farias, Sarah E., Amariglio, Rebecca E., Buckley, Rachel F., Visser, Pieter Jelle, Rentz, Dorene M., Johnson, Keith A., Properzi, Michael J., Schultz, Aaron, Donovan, Nancy, Gatchell, Jennifer R., Teunissen, Charlotte E., Van Berckel, Bart N. M., Van der Flier, Wiesje M., Sperling, Reisa A., Papp, Kathryn V., Scheltens, Philip, Marshall, Gad A., Sikkes, Sietske A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597034/ https://www.ncbi.nlm.nih.gov/pubmed/33121534 http://dx.doi.org/10.1186/s13195-020-00706-2

Ejemplares similares

Determining the Minimal Important Change of Everyday Functioning in Dementia: Pursuing Clinical Meaningfulness
por: Dubbelman, Mark A., et al.
Publicado: (2022)

Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report
por: Verrijp, Merike, et al.
Publicado: (2022)

Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity
por: Jutten, Roos J., et al.
Publicado: (2021)

Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
por: Buckley, Rachel F., et al.
Publicado: (2019)

Multiple markers contribute to risk of progression from normal to mild cognitive impairment
por: Rabin, Jennifer S., et al.
Publicado: (2020)

Relation of modifiable lifestyle and mood factors to cognitive concerns among participants and their study partners in the A4 screen data
por: Reynolds, Gretchen, et al.
Publicado: (2023)

Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
por: Samaroo, Aubryn, et al.
Publicado: (2021)

Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease
por: Jutten, Roos J., et al.
Publicado: (2022)

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
por: Rentz, Dorene M, et al.
Publicado: (2013)

Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system
por: Grober, Ellen, et al.
Publicado: (2021)

Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study
por: Marshall, Gad A., et al.
Publicado: (2020)

Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease
por: Halawa, Omar A., et al.
Publicado: (2019)

Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5
por: Papp, Kathryn V., et al.
Publicado: (2017)

Amyloid-associated increases in longitudinal report of subjective cognitive complaints
por: Amariglio, Rebecca E., et al.
Publicado: (2018)

Cross-cultural adaptation and validation of the Amsterdam Instrumental Activities of Daily Living questionnaire short version German for Switzerland
por: Bruderer-Hofstetter, Marina, et al.
Publicado: (2020)

Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals
por: Jacobs, Heidi I.L., et al.
Publicado: (2018)

Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging
por: Vannini, Patrizia, et al.
Publicado: (2017)

Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer’s Disease Biomarkers and Mood Symptoms
por: Munro, Catherine E., et al.
Publicado: (2022)

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results
por: Slot, Rosalinde E. R., et al.
Publicado: (2018)

Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi‐site cohort
por: Young, Christina B., et al.
Publicado: (2023)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
por: Willemse, Eline A. J., et al.
Publicado: (2021)

Giving meaning to the scores of the Amsterdam instrumental activities of daily living questionnaire: a qualitative study
por: Dubbelman, Mark A., et al.
Publicado: (2022)

Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults
por: Gatchel, Jennifer R., et al.
Publicado: (2019)

Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study
por: Grober, Ellen, et al.
Publicado: (2022)

Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults
por: ten Kate, Mara, et al.
Publicado: (2018)

Dutch Brain Research Registry for study participant recruitment: Design and first results
por: Zwan, Marissa D., et al.
Publicado: (2021)

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
por: Papp, Kathryn V., et al.
Publicado: (2021)

The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease
por: Vila-Castelar, Clara, et al.
Publicado: (2020)

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum
por: Dubbelman, Mark A., et al.
Publicado: (2023)

Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults
por: Vannini, Patrizia, et al.
Publicado: (2019)

Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments
por: Marshall, Gad A., et al.
Publicado: (2019)

Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease
por: Scheltens, Nienke M.E., et al.
Publicado: (2016)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
por: Babapour Mofrad, Rosha, et al.
Publicado: (2021)

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes
por: Pijnenburg, Yolande A.L., et al.
Publicado: (2015)

Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease
por: Scheltens, Nienke M.E., et al.
Publicado: (2019)

Regional tau pathology and loneliness in cognitively normal older adults
por: d’Oleire Uquillas, Federico, et al.
Publicado: (2018)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
por: ten Kate, Mara, et al.
Publicado: (2017)

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
por: Ebenau, Jarith L., et al.
Publicado: (2020)

Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire
por: Jutten, Roos J., et al.
Publicado: (2017)

The Cognitive Online Self‐Test Amsterdam (COST‐A): Establishing norm scores in a community‐dwelling population
por: Visser, Leonie N.C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c9gsfjth4g7vg8eq9rumdnrv7e